{"Welcome.html": {"id": "Welcome.html", "text": "Welcome", "displayed_text": "Welcome"}, "Task.html": {"id": "Task.html", "text": "Task", "displayed_text": "Task"}, "ChangeTypes.html": {"id": "ChangeTypes.html", "text": "ChangeTypes", "displayed_text": "ChangeTypes"}, "Consent.html": {"id": "Consent.html", "text": "Consent", "displayed_text": "Consent"}, "Navigation.html": {"id": "Navigation.html", "text": "Navigation", "displayed_text": "Navigation"}, "Medicine_56": {"DOI": "10.1001/jama.2014.15690", "id": "Medicine_56", "News Finding": "At 5 years after randomization, the cumulative primary event rate was similar in participants in the aspirin group (2.77 percent) and those in the no aspirin group (2.96 percent).", "Paper Finding": "The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% CI, 2.40%-3.20%] for aspirin vs 2.96% [95% CI, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% CI, 0.77-1.15]; P = .54).", "News Context": "The researchers found that there was no statistically significant difference between the two groups in time to the primary end point (a composite of death from cardiovascular causes, nonfatal stroke, and nonfatal heart attack). At 5 years after randomization, the cumulative primary event rate was similar in participants in the aspirin group (2.77 percent) and those in the no aspirin group (2.96 percent). Aspirin significantly reduced incidence of nonfatal heart attack and transient ischemic attack, and significantly increased the risk of extracranial hemorrhage requiring transfusion or hospitalization.", "Paper Context": "Patients with an occurrence of nonfatal stroke totaled 114 in the aspirin group and 108 in the no aspirin group; of nonfatal myocardial infarction, 20 in the aspirin group and 38 in the no aspirin group; of undefined cerebrovascular events, 3 in the aspirin group and 5 in the no aspirin group. The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% CI, 2.40%-3.20%] for aspirin vs 2.96% [95% CI, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% CI, 0.77-1.15]; P = .54). Aspirin significantly reduced incidence of nonfatal myocardial infarction (0.30 [95% CI, 0.19-0.47] for aspirin vs 0.58 [95% CI, 0.42-0.81] for no aspirin; HR, 0.53 [95% CI, 0.31-0.91]; P = .02) and transient ischemic attack (0.26 [95% CI, 0.16-0.42] for aspirin vs 0.49 [95% CI, 0.35-0.69] for no aspirin; HR, 0.57 [95% CI, 0.32-0.99]; P = .04), and significantly increased the risk of extracranial hemorrhage requiring transfusion or hospitalization (0.86 [95% CI, 0.67-1.11] for aspirin vs 0.51 [95% CI, 0.37-0.72] for no aspirin; HR, 1.85 [95% CI, 1.22-2.81]; P = .004).", "scores": "[5.0, 5.0, 4.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 4.75, "source": "news", "News URL": "http://www.newswise.com/articles/effect-of-once-daily-low-dose-aspirin-on-cv-death-and-other-outcomes", "text": "<b>Reported finding:</b> At 5 years after randomization, the cumulative primary event rate was similar in participants in the aspirin group (2.77 percent) and those in the no aspirin group (2.96 percent).<br><b>Paper finding:</b> The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% CI, 2.40%-3.20%] for aspirin vs 2.96% [95% CI, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% CI, 0.77-1.15]; P = .54).", "displayed_text": "<b>Reported finding:</b> At 5 years after randomization, the cumulative primary event rate was similar in participants in the aspirin group (2.77 percent) and those in the no aspirin group (2.96 percent).<br><b>Paper finding:</b> The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% CI, 2.40%-3.20%] for aspirin vs 2.96% [95% CI, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% CI, 0.77-1.15]; P = .54)."}, "Medicine_72": {"DOI": "10.1111/jgs.15671", "id": "Medicine_72", "News Finding": "The nurse practice environment was the best predictor of poor-quality end-of-life care.", "Paper Finding": "The best predictor of poor quality was the nurse practice environment.", "News Context": "The researchers found that 58 percent of nurses gave their hospitals an unfavorable evaluation of end-of-life care overall and 53 percent reported that patients often experience painful procedures that were unlikely to change their outcome. The nurse practice environment was the best predictor of poor-quality end-of-life care. Compared to nurses in poor-quality environments, nurses in the best environments were less likely to rate their hospital's overall end-of-life care quality unfavorably (odds ratio, 0.45).", "Paper Context": "The best predictor of poor quality was the nurse practice environment. Nurses in the best environments were 55% less likely than nurses in poor environments to rate their hospital's overall end-oflife care quality unfavorably (odds ratio = 0.45; 95% confidence interval = 0.39-0.52; P < .001). CONCLUSION: Quality of end-of-life care in US hospitals is imperfect and is significantly worse in hospitals with poor nurse practice environments than in hospitals with the best environments.", "scores": "[5.0, 4.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 4.666666666666667, "source": "news", "News URL": "http://ct.moreover.com/?a=38083013721&p=1pl&v=1&x=ehR_OuxwwqRLFfruA-gOJQ", "text": "<b>Reported finding:</b> The nurse practice environment was the best predictor of poor-quality end-of-life care.<br><b>Paper finding:</b> The best predictor of poor quality was the nurse practice environment.", "displayed_text": "<b>Reported finding:</b> The nurse practice environment was the best predictor of poor-quality end-of-life care.<br><b>Paper finding:</b> The best predictor of poor quality was the nurse practice environment."}, "Medicine_66": {"DOI": "10.1186/s13578-015-0003-4", "id": "Medicine_66", "News Finding": "We further found that PC increased H2S production rate and CSE expressions, and protected young hearts from I/R-induced cardiomyocytes damage, all of which were disappeared in the aging hearts.", "Paper Finding": "Taken together, our results indicated that aging rat hearts suffered from I/R injury and PC did not improve this injury.", "News Context": "I/R also increased the release of cytochrome c and down-regulated the phosphorylation of PI3K, Akt and GSK-3b in the aging rat hearts. We further found that PC increased H2S production rate and CSE expressions, and protected young hearts from I/R-induced cardiomyocytes damage, all of which were disappeared in the aging hearts. Supply of NaHS not only increased PC-induced cardioprotection in the young hearts, but also lightened I/R induced-myocardial damage and significantly recovered the cardioprotective role of PC against I/R induced myocardial damage in the aging hearts.", "Paper Context": "PC did not change the above mentioned indexes in comparison with the I/R (Figures 3, 4, 5 and 6 ). Taken together, our results indicated that aging rat hearts suffered from I/R injury and PC did not improve this injury. H 2 S produced by CSE in cardiovascular system acted as a physiological cardiac function regulator, which protected the cardiac function in ischemic reperfusion or hypoxia .", "scores": "[3.0, 4.0, 3.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 3.75, "source": "news", "News URL": "http://www.technology.org/2015/03/22/a-novel-target-for-the-treatment-of-aging-cardiovascular-diseases/", "text": "<b>Reported finding:</b> We further found that PC increased H2S production rate and CSE expressions, and protected young hearts from I/R-induced cardiomyocytes damage, all of which were disappeared in the aging hearts.<br><b>Paper finding:</b> Taken together, our results indicated that aging rat hearts suffered from I/R injury and PC did not improve this injury.", "displayed_text": "<b>Reported finding:</b> We further found that PC increased H2S production rate and CSE expressions, and protected young hearts from I/R-induced cardiomyocytes damage, all of which were disappeared in the aging hearts.<br><b>Paper finding:</b> Taken together, our results indicated that aging rat hearts suffered from I/R injury and PC did not improve this injury."}, "Experience.html": {"id": "Experience.html", "text": "Experience", "displayed_text": "Experience"}, "End.html": {"id": "End.html", "text": "End", "displayed_text": "End"}}